-
公开(公告)号:SK15222001A3
公开(公告)日:2002-06-04
申请号:SK15222001
申请日:2000-04-11
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , SCHULT SABINE , MULLER REINHOLD
IPC: C07D235/08 , A61K31/4184 , A61K31/4427 , A61K31/4523 , A61K31/496 , A61K31/551 , A61P3/10 , A61P9/00 , A61P9/10 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P35/04 , A61P43/00 , C07D235/10 , C07D235/12 , C07D235/14 , C07D235/16 , C07D401/08 , C07D403/08 , C07D235/06
Abstract: Compounds of the formula I or IIand their tautomeric forms, possible enantiomeric and diastereomeric forms, possible cistrans isomers on the rings in A and prodrugs thereof, pharmaceutical compositions containing these compounds and methods of treating neurodegenerative diseases or neuronal damage with these compounds.
-
公开(公告)号:CZ20011855A3
公开(公告)日:2001-08-15
申请号:CZ20011855
申请日:1999-11-23
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , SCHULT SABINE , GRANDEL ROLAND , MULLER REINHOLD
IPC: A61K20060101 , A61K31/4184 , A61K31/454 , A61K31/496 , A61P20060101 , A61P3/12 , A61P9/00 , A61P9/10 , A61P13/12 , A61P17/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D235/30 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: Compounds of the formula Ia or IB where A is a saturated or monounsaturated heterocyclic, 4 - to 8-membered ring which contains one or two nitrogen atoms, and their tautomeric forms, possible enantiomeric and diastereomeric forms, their prodrugs and possible physiologically tolerated salts are useful as inhibitors of the enzyme poly(ADP-ribose)polymerase.
-
公开(公告)号:CA2371645A1
公开(公告)日:2000-11-16
申请号:CA2371645
申请日:2000-04-27
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MULLER REINHOLD , GRANDEL ROLAND , HOGER THOMAS , KOCK MICHAEL , SCHULT SABINE , HOLZENKAMP UTA
IPC: C07D235/20 , A61K31/415 , A61K31/4184 , A61K31/422 , A61K31/427 , A61K31/437 , A61K31/4439 , A61K31/4709 , A61K31/496 , A61K31/497 , A61P3/10 , A61P9/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D235/18 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04 , C07D209/00 , C07D213/00 , C07D235/00
Abstract: The present invention relates to novel benzimidazoles, the production thereo f and the utilisation as inhibitors of the enzyme poly(ADP-ribose)polymerase o r PARP (EC 2.4.2.30) for producing medicaments.
-
公开(公告)号:NZ511825A
公开(公告)日:2003-08-29
申请号:NZ51182599
申请日:1999-11-23
Applicant: BASF AG
Inventor: KOCK MICHAEL , HOGER THOMAS , SCHULT SABINE , GRANDEL ROLAND , MULLER REINHOLD , LUBISCH WILFRIED
IPC: A61K20060101 , A61K31/4184 , A61K31/454 , A61K31/496 , A61P20060101 , A61P3/12 , A61P9/00 , A61P9/10 , A61P13/12 , A61P17/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D235/30 , C07D401/04 , C07D401/14 , C07D403/04 , A61P3/10 , A61K31/551 , A61K31/4545
Abstract: Compounds of general formula (Ia) or (Ib) wherein R-1 and R4 are hydrogen or defined substituents, A is a saturated or monoethenoid heterocyclic ring with 4 to 8 members which contains one or two nitrogen atoms, wherein additionally one oxygen or sulfur atom can be present. Said ring can be further substituted. The invention also relates to their tautomer forms, possible enantiomer and diastereomer forms, their prodrugs, as well as possible physiologically acceptable salts. The invention also relates to the use of said compounds for treating diseases related to a pathologically increased activity of PARP.
-
公开(公告)号:SK3802002A3
公开(公告)日:2003-03-04
申请号:SK3802002
申请日:2000-09-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , MULLER REINHOLD , SCHULT SABINE
-
26.
公开(公告)号:CZ20013775A3
公开(公告)日:2002-10-16
申请号:CZ20013775
申请日:2000-04-11
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , SCHULT SABINE , MULLER REINHOLD
IPC: C07D235/08 , A61K31/4184 , A61K31/4427 , A61K31/4523 , A61K31/496 , A61K31/551 , A61P3/10 , A61P9/00 , A61P9/10 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P35/04 , A61P43/00 , C07D235/10 , C07D235/12 , C07D235/14 , C07D235/16 , C07D401/08 , C07D403/08 , C07D235/06
Abstract: Compounds of the formula I or IIand their tautomeric forms, possible enantiomeric and diastereomeric forms, possible cistrans isomers on the rings in A and prodrugs thereof, pharmaceutical compositions containing these compounds and methods of treating neurodegenerative diseases or neuronal damage with these compounds.
-
公开(公告)号:CO5170500A1
公开(公告)日:2002-06-27
申请号:CO00028650
申请日:2000-04-18
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , SCHULT SABINE , MULLER REINHOLD
IPC: C07D235/08 , A61K31/165 , A61K31/415 , A61K31/4184 , A61K31/4427 , A61K31/4523 , A61K31/496 , A61K31/551 , A61P3/10 , A61P9/00 , A61P9/10 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P35/04 , A61P43/00 , C07D235/10 , C07D235/12 , C07D235/14 , C07D235/16 , C07D401/08 , C07D403/08
Abstract: Compuestos de las fórmulas I ó II: dondeA significa un carbociclo saturado o monoinsaturado con 3 a 8 átomos de carbono, que pueden tener adicionalmente un anillo benceno condensado, cuyos anillos pueden estar sustituidos adicionalmente por uno o dos radicales R3 idénticos o diferentes, así como el radical R4, yR1 hidrógeno, cloro, fluoro, bromo, yodo, C1-C6-alquilo ramificado y sin ramificar, OH, nitro, CF3, CN, NR11R12, NH-CO-R13, O-C1-C4-alquilo, significando R11 y R12, cada uno independientemente del otro, hidrógeno o C1-C4-alquilo yR13 hidrógeno, C1-C4-alquilo, C1-C4-alquil-fenilo o fenilo,YR2 significa hidrógeno, C1-C6-alquilo ramificado y sin ramificar, C1-C4-alquilo, fenilo yR3 significa C1-C6-alquilo, OH, O-C1-C4-alquilo, OC1-C4-alquil-fenilo, NR11R12, fenilo, C1-C4-alquil-fenilo, CF3, COOH, COOC1-C4-alquilo, CONH-C1-C4-alquilo, CONH2, pudiendo los anillos fenilo estar sustituidos aún por, como máximo, dos radicales R31 idénticos o diferentes, yR31 significa OH, C1-C6-alquilo, OC1-C4-alquilo, cloro, bromo, yodo, fluoro, CF3, nitro, NH2, y R4 significa -(O)p.(CH2)q-B, dondeB es NR41R42 SignificandoP 0 y 1 yq 0, 1, 2 ó 3, pudiendo, cuando q = 0 p también ser igual a 0, y- 2 -R41 significa hidrógeno, C1-C6-alquilo, (CH2)r-E yR42 significa hidrógeno, C1-C6-alquilo, -CO-R8, SO2-R8, -(C=N)-R8 y -(C=N)- NHR8 yr es 0,1,2,3,4 yE significa fenilo, que puede llevar aún, como máximo dos radicales R72, y, cuando r ? 0, 1, también NR11R12, NH-C1-C4-alquil-fenilo, pirrolidina, piperidina, dihidropiperidina, morfolina, homopiperidina, piperacina, que puede estar sustituída aún por C1-C6-alquilo y C1-C6-alquil-fenilo, y homopiperacina, que puede estar sustituída aún por C1-C6-alquilo y C1-C4-alquil-fenilo, yR7 significa hidrógeno, C1-C6-alquilo, fenilo, pudiendo el anillo estar sustituido aún por hasta dos radicales R71 idénticos o diferentes, yR71 significa OH, C1-C6-alquilo, O-C1-C4-alquilo, cloro, bromo, yodo, fluoro, CF3, nitro, NR11R12, yR72 significa OH, C1-C6-alquilo, O-C1-C4-alquilo, cloro, bromo, yodo, fluoro, CF3, nitro, NR11R12, yR8 significa C1-C6-alquilo, fenilo, C1-C4-alquil-fenilo, pudiendo el anillo estar sustituído aún por hasta dos radicales R81 idénticos o diferentes, yR81 significa OH, C1-C6-alquilo, O-C1-C4-alquilo, cloro, bromo, yodo, fluoro, CF3, nitro, NR11R12, yR9 significa hidrógeno, C1-C6-alquilo, C1-C4-alquil-fenilo, fenilo, pudiendo el anillo estar sustituido aún por hasta dos radicales R91 idénticos o diferentes, y R91 significa OH, C1-C6-alquilo, O-C1-C4-alquilo, cloro, bromo, yodo, fluoro, CF3, nitro NR11R12,así como sus formas tautómeras, sus formas enantiómeras y diastereómeras posibles, los isómeros cis.-trans en los anillos A y sus prodrogas.
-
公开(公告)号:SK8842001A3
公开(公告)日:2002-01-07
申请号:SK8842001
申请日:2000-09-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , SCHULT SABINE , GRANDEL ROLAND , MULLER REINHOLD
IPC: A61K31/55 , A61P3/10 , A61P9/10 , A61P11/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P35/00 , C07D487/06
Abstract: The invention relates to compounds of formula (I) as well as to the tautomeric forms thereof, possible enantiomeric and diastereomeric forms and the prodrugs thereof, the production and use thereof, whereby the values have the meaning as given in the description.
-
公开(公告)号:AU1271201A
公开(公告)日:2001-04-30
申请号:AU1271201
申请日:2000-09-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , MULLER REINHOLD , SCHULT SABINE
IPC: A61K31/55 , A61P3/10 , A61P9/10 , A61P11/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P35/00 , C07D487/06 , C07D223/00 , C07D209/00
Abstract: The invention relates to compounds of formula (I) as well as to the tautomeric forms thereof, possible enantiomeric and diastereomeric forms and the prodrugs thereof, the production and use thereof, whereby the values have the meaning as given in the description.
-
公开(公告)号:AU4558400A
公开(公告)日:2000-11-21
申请号:AU4558400
申请日:2000-04-27
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , KOCK MICHAEL , HOGER THOMAS , GRANDEL ROLAND , HOLZENKAMP UTA , SCHULT SABINE , MULLER REINHOLD
IPC: C07D235/20 , A61K31/415 , A61K31/4184 , A61K31/422 , A61K31/427 , A61K31/437 , A61K31/4439 , A61K31/4709 , A61K31/496 , A61K31/497 , A61P3/10 , A61P9/00 , A61P13/12 , A61P19/02 , A61P25/00 , A61P25/08 , A61P25/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D235/18 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04
Abstract: The present invention relates to novel benzimidazoles, their preparation and their use as inhibitors of the enzyme poly(ADP-ribose) polymerase or PARP (EC 2.4.2.30) for producing drugs.
-
-
-
-
-
-
-
-
-